Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Short-term Investments: 2024

Historic Short-term Investments for Praxis Precision Medicines (PRAX) over the last 1 years, with Dec 2024 value amounting to $177.2 million.

  • Praxis Precision Medicines' Short-term Investments fell 37.56% to $117.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.6 million, marking a year-over-year decrease of 37.56%. This contributed to the annual value of $177.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Praxis Precision Medicines reported Short-term Investments of $177.2 million as of FY2024.
  • Praxis Precision Medicines' 5-year Short-term Investments high stood at $177.2 million for FY2024, and its period low was $177.2 million during FY2024.
  • For the 1-year period, Praxis Precision Medicines' Short-term Investments averaged around $177.2 million, with its median value being $177.2 million (2024).